Fractal and noisy CBV dynamics in humans:: influence of age and gender

被引:24
|
作者
Eke, Andras [1 ]
Herman, Peter [1 ]
Hajnal, Marton [1 ]
机构
[1] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1446 Budapest, Hungary
来源
关键词
cerebral blood volume; chaos; fractals; geriatrics; infrared spectroscopy; menopause;
D O I
10.1038/sj.jcbfm.9600243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The complexity of spontaneous cerebral blood volume (CBV) fluctuations can emerge from random, fractal, or chaotic processes. Our aims were to define the contribution of these patterns to the observed complexity and to evaluate the effect of age and gender on it. The total hemoglobin content as the measure of CBV was monitored by near-infrared spectroscopy on volunteers (men n = 19, age = 20 to 78 years; women n = 23, age = 21 to 79 years). Random and fractal patterns were distinguished by the spectral index (beta). Chaos was identified by surrogate analysis of the correlation dimension (a static chaotic parameter, the dimension of the correlation integral) and the largest Lyapunov exponent (a dynamic chaotic parameter, the rate of exponential divergence of the system states from a perturbed initial condition over the chaotic attractor). In spontaneous CBV fluctuations, both fast random and slow fractal dynamics are present separately in their spectra by a cutoff frequency, f'. Below f' the pattern is fractal, in that power rises inversely with frequency as 1/f(beta). f' decreases with age in men and women alike (F1: up to 0.12 +/- 0.06 Hz versus F2: up to 0.05 +/- 0.04 Hz at P = 0.015, and M1: up to 0.16 +/- 0.05 Hz versus M2: up to 0.11 +/- 0.04 Hz at P = 0.044). Neither pre- nor postmenopausal age groups (1 and 2, respectively) showed a (low)beta gender difference. Surrogate analysis showed that CBV dynamics cannot be characterized on the grounds of deterministic chaos. Cerebral blood volume fluctuates in a complex, bimodal manner in humans, in that the fast dynamics has no structure, while the slow dynamics exhibits a self-similar, that is, fractal temporal structure. The range of fluctuation amplitudes produced by fractal dynamics is always larger than that of random fluctuations, and it shrinks with an altered structuring in aging women only.
引用
收藏
页码:891 / 898
页数:8
相关论文
共 50 条
  • [21] THE INFLUENCE OF AGE ON SALICYLATE PHARMACOKINETICS IN HUMANS
    ABDALLAH, HY
    MAYERSOHN, M
    CONRAD, KA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04): : 380 - 387
  • [22] Age and gender specific biokinetic model for strontium in humans
    Shagina, N. B.
    Tolstykh, E. I.
    Degteva, M. O.
    Anspaugh, L. R.
    Napier, B. A.
    JOURNAL OF RADIOLOGICAL PROTECTION, 2015, 35 (01) : 87 - 127
  • [23] Influence of noise on dynamics with fractal Fourier spectra
    Zaks, MA
    PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS, 2002, 310 (3-4) : 285 - 307
  • [24] Age related changes in accommodative dynamics in humans
    Kasthurirangan, S
    Glasser, A
    VISION RESEARCH, 2006, 46 (8-9) : 1507 - 1519
  • [25] Age related changes in accommodative dynamics in humans
    Schachar, Ronald A.
    VISION RESEARCH, 2007, 47 (15) : 2111 - 2112
  • [26] Bimanual Coordination: Influence of Age and Gender
    Shetty, Ashwini K.
    Shankar, Vinutha M. S.
    Annamalai, Nachal
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (02) : 15 - 16
  • [27] Influence of Age and Gender in Takotsubo Syndrome
    Schneider, Birke
    Sechtem, Udo
    HEART FAILURE CLINICS, 2016, 12 (04) : 521 - +
  • [28] The Influence of Age and Gender on the Pharmacokinetics of Moxifloxacin
    John T. Sullivan
    John T. Lettieri
    Patrick Liu
    Allen H. Heller
    Susan J. Watson
    Clinical Pharmacokinetics, 2001, 40 : 11 - 18
  • [29] THE INFLUENCE OF AGE AND GENDER ON RADIAL HEIGHT
    MANN, FA
    RAISSDANA, SS
    WILSON, AJ
    GILULA, LA
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1993, 18A (04): : 711 - 713
  • [30] The influence of age and gender on the pharmacokinetics of moxifloxacin
    Sullivan, JT
    Lettieri, JT
    Liu, P
    Heller, AH
    CLINICAL PHARMACOKINETICS, 2001, 40 (Suppl 1) : 11 - 18